Popular Trials
Non-invasive Brain Stimulation
tDCS for Cognitive Impairment in Parkinson's Disease
This trial aims to use a novel personalized network analysis approach to elucidate the mechanisms of the effect of tDCS on cognitive dysfunction in non-demented PD patients.
Procedure
Deep Brain Stimulation Adjustments for Parkinson's Disease
This trial looks at how different locations and frequencies of electrical stimulation to the subthalamic nucleus (a deep brain structure) affects cognition in Parkinson's patients who have had deep brain stimulation surgery.
Behavioural Intervention
Movement-2-Music Exercise Program for Mobility Disabilities
This trial is testing the effects of an innovative exercise program, movement-2-music (M2M), on health and fitness outcomes in adults with physical/mobility disabilities. One hundred and eight participants will be recruited and randomly enrolled into one of two groups: M2M or waitlist control. The primary aim of this study is to determine the effects of the 12-week M2M program on health and fitness in participants with physical/mobility disabilities. The study will also compare the observed effects of the program to a previous M2M study, and test whether adherence (attendance to the 12-week program) affects the
Cytokine
Leukine for Parkinson's Disease
This trial is testing the safety of a 24-month regimen of Leukine as a treatment for Parkinson's disease. Clinical signs and symptoms will be measured by personal well-being, physical, and neurological examinations, and blood tests. The investigators will also assess the tolerability of the regimen and the effects of treatment on immune deficits in PD.
Popular Filters
Trials for Parkinson's Disease Patients
Radiation
Radiosurgery for Essential Tremor
This trial is testing a non-surgical radiation treatment to help people with severe tremors from Essential Tremor or Parkinson's Disease who can't have traditional brain surgery. The treatment aims to reduce shaking by targeting specific brain areas with precise radiation. This minimally invasive alternative to traditional brain surgery is designed for treating tremors in conditions like Essential Tremor and Parkinson's Disease.
Behavioural Intervention
Electrical Brain Stimulation for Parkinson's Disease
This trial is testing whether electrical stimulation of the brain can help reduce cognitive fatigue and improve cognitive function in patients with Parkinson's disease and mild cognitive impairment.
Trials for PD Patients
Radiation
Radiosurgery for Essential Tremor
This trial is testing a non-surgical radiation treatment to help people with severe tremors from Essential Tremor or Parkinson's Disease who can't have traditional brain surgery. The treatment aims to reduce shaking by targeting specific brain areas with precise radiation. This minimally invasive alternative to traditional brain surgery is designed for treating tremors in conditions like Essential Tremor and Parkinson's Disease.
Behavioural Intervention
Electrical Brain Stimulation for Parkinson's Disease
This trial is testing whether electrical stimulation of the brain can help reduce cognitive fatigue and improve cognitive function in patients with Parkinson's disease and mild cognitive impairment.
Trials With No Placebo
Radiation
Radiosurgery for Essential Tremor
This trial is testing a non-surgical radiation treatment to help people with severe tremors from Essential Tremor or Parkinson's Disease who can't have traditional brain surgery. The treatment aims to reduce shaking by targeting specific brain areas with precise radiation. This minimally invasive alternative to traditional brain surgery is designed for treating tremors in conditions like Essential Tremor and Parkinson's Disease.
Procedure
Deep Brain Stimulation for Parkinson's Disease
This trial is testing different types of deep brain stimulation to see which is most effective in treating Parkinson's, essential tremor, and multiple sclerosis. The results will help design more effective stimulation patterns and aid in understanding how DBS works.
View More Related Trials
Frequently Asked Questions
Introduction to parkinson disease
What are the top hospitals conducting parkinson disease research?
When it comes to the pursuit of new treatments and breakthroughs for [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease), several leading hospitals are at the forefront. In Nashville, Tennessee, Vanderbilt University Medical Center is making significant strides with five ongoing clinical trials focused on this debilitating condition. With a total of 26 trials conducted to date since their first recorded trial in 2007, Vanderbilt University Medical Center has established itself as a key player in Parkinson's research.
Meanwhile, the University of Florida in Gainesville has been actively pursuing solutions for Parkinson's disease as well. Currently engaged in four active clinical trials and having conducted 36 trials overall since their inaugural study in 2004, they have contributed significantly to advancing our understanding of this complex neurological disorder.
Another notable institution is the University of Alabama at Birmingham located in Birmingham. Like its counterpart in Gainesville, it too boasts four active clinical trials for Parkinson's disease and shares an equal tally of 36 completed studies thus far starting from their earliest recorded trial also dating back to 2004.
Stanford University joins this group with four ongoing clinical trials dedicated to investigating better treatment options for individuals living with Parkinson's disease. While having conducted ten previous studies related to this condition since initiating their first trial in 2008 makes them a formidable force within the field.
Lastly but not least,the Cleveland Clinic situated conveniently right within Cleveland; while conducting same number(4)of current running parkinson-disease-specific experiments similar like other peer institutions mentioned above but astonishingly surpasses all by holding thirty-eight past extensive investigations regarding parkinson diseasesince performing very first one way back during year two thousand six (which indeed puts them on top among participating members)
These esteemed medical centers serve as beacons of hope for patients battling Parkinson's disease worldwide. Through relentless dedication and innovative thinking exhibited by these hospitals' researchers,and physicians alike we can rest assured that every endeavor brings us closer towards finding effective treatments which shall surely make vast difference enhancing lives of millions suffering from this neurological condition.
Which are the best cities for parkinson disease clinical trials?
When it comes to [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease) clinical trials, several cities emerge as leaders in research and development. New york City boasts 13 active trials exploring treatments like LY3884961, Zoledronic acid (ZA), and ExAblate Pallidotomy. Philadelphia follows closely with 11 ongoing studies focused on interventions such as Gameficiation and Waitlist Couple Pairs Parkinson's Group. Boston also offers 11 active trials examining options like mHealth delivered exercise programs and Digital music therapy. Chicago contributes to the field with 10 studies investigating treatments including Sulvecaltamide and Treadmill walking. Lastly, Miami is home to nine active trials that explore interventions such as Rock Steady Boxing classes and JM-010 combination Group B treatment. These cities provide individuals living with Parkinson's disease access to cutting-edge clinical trials that pave the way for advancements in care and improve quality of life.
Which are the top treatments for parkinson disease being explored in clinical trials?
Recent clinical trials have shed light on the top treatments being explored for [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease). Among these potential game-changers is Felix, which has shown promise in one active trial dedicated to this neurodegenerative disorder. Additionally, Inspiratory Muscle Training has also caught researchers' attention with its positive results in a separate trial. Lastly, advanced treadmill walking has emerged as another avenue of exploration, showing encouraging outcomes in early studies. These breakthroughs offer hope for individuals living with Parkinson's disease and pave the way for improved management and treatment options moving forward.
What are the most recent clinical trials for parkinson disease?
Recent clinical trials for [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease) offer promising insights and potential breakthroughs in the field. One notable study is focused on eiDBS suppression, a Phase 4 trial that investigates the effectiveness of deep brain stimulation to alleviate symptoms associated with Parkinson's disease. Another trial, known as Waitlist Couple Pairs Parkinson's Group, explores innovative strategies to support individuals affected by this condition through group therapy sessions. Additionally, the i-BiSSkApp Group trial aims to evaluate the efficacy of a specific app in managing symptoms. The Delayed Start-PD study investigates whether delaying treatment initiation affects long-term outcomes for patients with Parkinson's disease. Lastly, IkT-148009 presently undergoes a Phase 2 trial to assess its potential therapeutic benefits in alleviating symptoms related to this neurodegenerative disorder.
What parkinson disease clinical trials were recently completed?
In the realm of [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease) research, numerous clinical trials have recently concluded, showcasing the commitment to finding effective treatments for this debilitating condition. Notably, Five Eleven Pharma completed a trial investigating [18F]P17-059 in July 2022. Additionally, AbbVie wrapped up their ABBV-951 trial along with BioVie Inc.'s NE3107 study in January 2022. These accomplishments are complemented by previous breakthroughs such as Michael J. Fox Foundation for Parkinson's Research concluding their [18F] PI-2620 trial in August 2021 and Eisai Inc.'s completion of the E2027 trial in February 2021. Each milestone brings hope closer for patients living with Parkinson's disease and highlights the tireless efforts made by researchers striving to improve their lives.